Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, BS | - |
dc.contributor.author | Chu, S | - |
dc.contributor.author | Lee, KC | - |
dc.contributor.author | Lee, BS | - |
dc.contributor.author | Chi, DY | - |
dc.contributor.author | Choe, YS | - |
dc.contributor.author | Kirn, SE | - |
dc.contributor.author | Song, YS | - |
dc.contributor.author | Jin, C | - |
dc.date.accessioned | 2024-01-21T08:03:04Z | - |
dc.date.available | 2024-01-21T08:03:04Z | - |
dc.date.created | 2021-09-03 | - |
dc.date.issued | 2003-11-17 | - |
dc.identifier.issn | 0968-0896 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/138081 | - |
dc.description.abstract | 3-(3-[F-18]Fluoropropyl)-6-nitroquipazine ([F-18]FPNQ) as a 5-HT transporter imaging agents was designed, synthesized, and evaluated. FPNQ was selected due to its potent in vitro biological activity (K-i = 0.32 nM) in rat brain cortical membranes. The F-18-labeled FPNQ was prepared by reaction of the propyl mesylate as a precursor with tetra-n-butylammonium [F-18]fluoride generated under NCA conditions. The precursor mesylate was synthesized from commercially available hydrocarbostyril in nine steps in 21% overall yield. The specific activity of the [F-18]FPNQ determined by radioreceptor assay was 27.0 GBq/mumol. Tissue distribution studies in mice showed the highest uptake in the frontal cortex (5.79 %ID/g) at 60 min post-injection. (C) 2003 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | POSITRON-EMISSION-TOMOGRAPHY | - |
dc.subject | 5-HYDROXYTRYPTAMINE UPTAKE COMPLEX | - |
dc.subject | DOPAMINE TRANSPORTER | - |
dc.subject | H-3 6-NITROQUIPAZINE | - |
dc.subject | IN-VIVO | - |
dc.subject | I-125 5-IODO-6-NITROQUIPAZINE | - |
dc.subject | PARKINSONS-DISEASE | - |
dc.subject | SELECTIVE LIGAND | - |
dc.subject | UPTAKE SITES | - |
dc.subject | RAT-BRAIN | - |
dc.title | Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter: Part 3. A potential 5-HT transporter imaging agent, 3-(3-[F-18]fluoropropyl)-6-nitroquipazine | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bmc.2003.09.009 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY, v.11, no.23, pp.4949 - 4958 | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY | - |
dc.citation.volume | 11 | - |
dc.citation.number | 23 | - |
dc.citation.startPage | 4949 | - |
dc.citation.endPage | 4958 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000186614400011 | - |
dc.identifier.scopusid | 2-s2.0-0242298240 | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | POSITRON-EMISSION-TOMOGRAPHY | - |
dc.subject.keywordPlus | 5-HYDROXYTRYPTAMINE UPTAKE COMPLEX | - |
dc.subject.keywordPlus | DOPAMINE TRANSPORTER | - |
dc.subject.keywordPlus | H-3 6-NITROQUIPAZINE | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | I-125 5-IODO-6-NITROQUIPAZINE | - |
dc.subject.keywordPlus | PARKINSONS-DISEASE | - |
dc.subject.keywordPlus | SELECTIVE LIGAND | - |
dc.subject.keywordPlus | UPTAKE SITES | - |
dc.subject.keywordPlus | RAT-BRAIN | - |
dc.subject.keywordAuthor | serotonin transporter | - |
dc.subject.keywordAuthor | 6-nitroquipazine analogues | - |
dc.subject.keywordAuthor | binding affinities | - |
dc.subject.keywordAuthor | imaging agent | - |
dc.subject.keywordAuthor | 3-(3-[18F]fluoropropyl)-6-nitroquipazine | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.